CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Cardioprotective effect of sitagliptin in type 2 diabetes mellitus

Author: 
Dr. Hesham Mohammad Sha’aban, Ayman Abdou Elhosiny and Prof. Tarek Mahrous Salman
Subject Area: 
Health Sciences
Abstract: 

Background: Recently, The dipeptidyl peptidase-4 (DPP-4) inhibitor, sitagliptin contributes to improvement of postprandial hyperglycemia and prevents risk of hypoglycemia through increasing the level of glucagon-like polypeptide (GLP-1) as new therapeutic target and novel pathway for correcting impaired glucose homeostasis in type 2 diabetes mellitus (T2DM). Aim: This study was conducted to assess the cardioprotective effect of sitagliptin on cardiovascular complications in Egyptian male patients with T2DM. Methods: The study enrolled 12 apparently healthy control subjects, 20 diabetic patients having no cardiovascular complications on 1 gm metformin orally daily for 3 months and 25 diabetic patients having cardiovascular complications on 1 gm metformin orally daily for 3 months then adding 100 mg Sitagliptin orally daily for 3 months. All subjects involved in this study are males having index of central obesity(ICO) < 0.55 The following parameters involved in this study are fasting plasma glucose (FPG), Glycated hemoglobin (HbA1C), insulin, proinsulin, proinsulin/insulin (PI/IN) ratio, hemostasis model assessment of insulin resistance (HOMA-IR), total cholesterol (TC), triglycerides (TG), low density lipoprotein (LDL), high density lipoprotein (HDL), very low density lipoprotein (VLDL), oxidized low density lipoprotein (Ox-LDL), risk ratio 1&2 (RR1)(RR2), creatine kinase MB (CK-MB), lactate dehydrogenase (LDH), plasminogen activator inhibitor-1 (PAI-1), cardiac troponin-I (cTnI), and homocysteine Results: Sitagliptin significantly reduced FPG, HbA1C, insulin, proinsulin, proinsulin/insulin ratio, HOMA-IR index, TC, TG, LDL, VLDL, OX-LDL, RR 1, RR 2, CK-MB, LDH, PAI-1, cTnI AND homocysteine compared to non Sitagliptin group, whereas HDL was significantly increased in sitagliptin group compared to non Sitagliptin group. Conclusion: Sitagliptin is effective not only on glycaemic control and insulin sensitivity but, also it ameliorates dyslipidemia, endothelial dysfunction and cardiovascular complications and in T2DM.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran